Patricia A. Martin is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 3,166 shares of ANTX, which is worth approximately $4,559. The most recent transaction as insider was on Dec 19, 2024, when has been sold 3,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.17K
n/a 3M change
n/a 12M change
Total Value Held $4,559

Patricia A. Martin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
BUY
Grant, award, or other acquisition
-
3,166 Added 50.0%
3,166 Common Stock

Also insider at

LPTX
LEAP THERAPEUTICS, INC. Healthcare
PAM

Patricia A. Martin

Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Track Activities on ANTX